Brief: MiMedx Group Engages Nordic Bioscience Clinical Development A/S To Propel Registrational Trials Of Placental Biologic Injectable For Knee Osteoarthritis
June 15 (Reuters) - MiMedx Group Inc MDXG.O :
* MIMEDX ENGAGES NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S
TO
PROPEL REGISTRATIONAL TRIALS OF PLACENTAL BIOLOGIC INJECTABLE
FOR KNEE OSTEOARTHRITIS
Source text for Eikon: ID:nGNXbsxDWm
Further company coverage: MDXG.O
((reuters.briefs@thomsonreuters.com;))
Recent news on MiMedx
See all newsMiMedx Q1 sales fall 33%, miss estimates, cuts 2026 outlook
Brief: MiMedx Q1 Sales USD 58.991 Million Vs. IBES Estimate USD 65 Million
MiMedx beats Q4 sales estimates; announces $100 mln share buyback
Brief: MiMedx Q4 Sales USD 118.095 Million Vs. IBES Estimate USD 106.8 Million
MiMedx Q3 net sales beat estimates